News | Cardiac Imaging | February 11, 2019

New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease

Guidance document from 10 societies discusses assessment of cardiac structure and function

New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease

February 11, 2019 — The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a new guidance document for appropriate use criteria (AUC) for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease. The guidance was published online Jan. 7 in the Journal of the American College of Cardiology (JACC).

This document is the second of two companion AUC documents. The first document addresses the evaluation and use of multimodality imaging in the diagnosis and management of valvular heart disease, whereas this document addresses this topic with regard to structural (nonvalvular) heart disease. While dealing with different subjects, the two documents do share a common structure and feature some clinical overlap. The goal of the companion AUC documents is to provide a comprehensive resource for multimodality imaging in the context of structural and valvular heart disease, encompassing multiple imaging modalities.

For more information: www.acc.org

Reference

1. Doherty J.U., Kort S., Mehran R., et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease. Journal of the American College of Cardiology, Jan. 7, 2019. https://doi.org/10.1016/j.jacc.2018.10.038

Related Content

Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug...
Three Palm Software Releases WorkstationOne Version 1.8.8
Technology | Mammography Reporting Software | June 12, 2019
Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
SCCT Announces 2019 Gold Medal Award Recipients
News | Computed Tomography (CT) | June 05, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M....
At ACC 2019, Siemens unveiled a version of its go.Top CT optimized for cardiovascular imaging. The newly packaged scanner can generate data needed to do  CT-based FFR (fractional flow reserve).

At ACC 2019, Siemens unveiled a version of its go.Top CT optimized for cardiovascular imaging. The newly packaged scanner can generate data needed to do
CT-based FFR (fractional flow reserve).

Feature | Cardiac Imaging | May 31, 2019 | By Greg Freiherr
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the ann
Baylor Scott White Heart Hospital Siemens Flash CT system used for dedicated cardiac CT scans, CCTA, CTA.
360 Photos | CT Angiography (CTA) | May 20, 2019
This is a 360 degree photo of a Siemens Somatom Force 64-slice, dual-source computed tomography (CT) system installed
360 Photos | Cardiac Imaging | May 20, 2019
A 360 degree photo view of a Siemens Healthineers digital radiography (DR) room install and mobile Carestream DRX mob
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.
360 Photos | Angiography | May 17, 2019
This is a view inside one of the 11 cath labs at ...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...